Allergan, Abbott, Boston Scientific chiefs make list of highest-paid U.S. public CEOs

April 8, 2013 by Arezu Sarvestani

CEOs from Allergan, Baxter, Abbott and Boston Scientific rank among the 100 top-paid CEOs of public U.S. companies, according to a New York Times 2012 tally.

CEO salaries illustration

Medtech workers may earn more than their peers on average, but medical device CEOs had a limited presence on New York Times' 2012 list of the 100 highest-paid CEOs of public U.S. companies.

Beginning from the bottom up, Boston Scientific (NYSE:BSX) CEO Michael Mahoney ranked 92nd with $10.6 million in total compensation in 2012 and Abbott (NYSE:ABT) CEO Miles White ranked 32nd with $19 million. White's 2012 package was 2% higher than the $18.6 million he recieved in total compensation in 2011; Mahoney's 2011 compenstaion wasn't provided.

Sign up to get our free newsletters delivered right to your inbox.

Baxter (NYSE:BAX) chief Robert Parkinson Jr. took the 23rd spot with $16 million in 2012, which was a quarter more than the $12.8 million reported for 2011.

Comments